Citius Pharmaceuticals In... (CTXR)

AI Score

Unlock

1.02

-0.16 (-13.56%)

At close: Apr 03, 2025, 3:59 PM

1.05

2.44%

After-hours: Apr 03, 2025, 07:48 PM EDT

Citius Pharmaceuticals Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012	Sep 30, 2011
Cash & Equivalents	3.25M	26.48M	41.71M	70.07M	13.86M	7.89M	9.18M	3.2M	294.35K	676.14K	1.55M	54.39K	135.00	212.00
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	29.18M	16.92M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	92.84M	38.06K	39.97M	38.06K	57.09K	57.09K	2.17K	2.17K	66.97K	n/a	n/a	n/a	-5.4	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	818.34K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	8.27M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.7M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	39K	n/a	n/a
Total Current Assets	14.22M	34.37M	44.56M	72.81M	13.98M	7.94M	10.06M	3.42M	892.84K	736.14K	1.55M	102.56K	135.00	212.00
Property-Plant & Equipment	246.25K	455.86K	650.17K	829.85K	987.78K	590.00	1.48K	3.24K	3.74K	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	9.35M	68.75M	68.75M	68.75M	28.75M	20.99M	20.99M	20.99M	20.99M	5.4K	5.4K	5.4K	5.40	n/a
Total Long-Term Assets	102.43M	69.24M	69.44M	69.61M	29.79M	21.04M	20.99M	20.99M	21.06M	5.4K	5.4K	5.4K	5.40	n/a
Total Assets	116.65M	103.61M	114M	142.43M	43.77M	28.99M	31.05M	24.42M	21.95M	741.54K	1.56M	107.97K	135.00	212.00
Account Payables	4.93M	2.93M	1.17M	1.28M	1.86M	2.71M	1.57M	602.43K	909.16K	559.15K	106.17K	11.47K	n/a	906.00
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.92M	n/a	142.28K	n/a	-97.39	n/a
Short-Term Debt	241.55K	n/a	196.99K	177.24K	331.97K	172.97K	172.97K	172.97K	672.97K	n/a	600K	3.21K	n/a	n/a
Other Current Liabilities	30.63M	n/a	1.57M	1.73M	1.5M	320.52K	n/a	n/a	2.67M	809.34K	1.51M	n/a	17.05K	n/a
Total Current Liabilities	35.81M	5.78M	4.53M	3.98M	4.1M	4.61M	3.18M	2.47M	5.18M	1.38M	2.3M	14.69K	45.98K	24.05K
Long-Term Debt	21.32K	n/a	n/a	n/a	164.58K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	6.74M	6.4M	6.04M	5.66M	6.01M	4.99M	1.75M	n/a	n/a	n/a	n/a	1.69M	1.46K	n/a
Total Liabilities	42.55M	12.18M	10.57M	9.65M	10.1M	4.61M	3.18M	2.47M	5.18M	1.38M	2.3M	14.69K	45.98K	24.05K
Total Debt	262.87K	481.25K	678.23K	855.47K	1.35M	172.97K	172.97K	172.97K	672.97K	n/a	600K	3.21K	17.05K	18.49K
Common Stock	7.25K	158.86K	146.21K	145.98K	55.58K	28.93K	16.2K	8.35K	73.14K	34.12K	30.02K	18K	18K	18K
Retained Earnings	-201.37M	-162.23M	-129.69M	-96.05M	-70.59M	-55.82M	-40.26M	-27.72M	-17.34M	-9.04M	-6.14M	-95.22K	-63.85K	-41.84K
Comprehensive Income	n/a	n/a	n/a	n/a	0.00	n/a	0.00	0.00	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	70.08M	90.83M	102.83M	132.18M	33.67M	24.38M	27.87M	21.95M	16.77M	-635.21K	-741.93K	-14.69K	-45.85K	-23.84K
Total Investments	n/a	n/a	n/a	29.18M	16.92M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a